Use of Synchronous, Interruptive Electronic Health Record–Embedded Medication Alerts to Improve Evidence-Based Medication Prescribing: Randomized Comparative Effectiveness Trial of Two Prescriber Alerts

Background Antithrombotic stewardship is critical for reducing preventable harm from inappropriate anticoagulant prescribing. Electronic health record (EHR)–embedded clinical decision support (CDS) alerts can prevent prescribing errors at the point of care, but their real-world effectiveness is variable and often limited by alert fatigue and poor workflow integration. Whether augmenting interruptive medication alerts with just‑in‑time access to clinical pharmacists improves prescriber response remains unclear. Objective This study aimed to (1) compare the effectiveness of synchronous, interruptive direct oral anticoagulant (DOAC) prescribing alerts with and without an embedded clinical pharmacist referral option for correcting inappropriate new prescriptions within 7 days, and (2) evaluate the system‑level impact of implementing synchronous DOAC alerts on inappropriate prescribing over time. Methods We conducted a prescriber‑level randomized comparative effectiveness trial within a large US academic health system. Prescribers who placed an inappropriate ambulatory apixaban or rivaroxaban order were randomized to receive an interruptive EHR alert either with or without an embedded clinical pharmacist referral link. The primary outcome was any change to the prescription within 7 days. In parallel, a system‑level interrupted time series analysis examined weekly proportions of inappropriate DOAC prescriptions (secondary outcomes) from 24 months before through 29 months after alert implementation. Exploratory outcomes included adverse events within 30 days and alert implementation metrics. Results Among 2082 prescribers writing DOAC prescriptions during the study period, 300 (14.4%) triggered at least one inappropriate prescription and were randomized; after prespecified exclusions, 758 alerts across 286 prescribers were analyzed. Overall, 28.9% (219/758) of alerts led to a prescription change within 7 days. The proportion of alerts leading to a prescription change did not differ between alerts with and without pharmacist referral (difference 1 percentage point [95% CI −7 to 9]). The system‑wide proportion of inappropriate DOAC prescriptions exhibited a significant downward preimplementation trend (−0.04 percentage points per week [95% CI −0.06 to −0.02]), followed by an immediate 3.5‑percentage‑point absolute reduction at alert launch (to 9.7%), with no subsequent slope change. Adverse events within 30 days were uncommon and similar across arms. Conclusions Adding an embedded pharmacist referral option to an interruptive DOAC prescribing alert did not increase short‑term prescription changes. However, the implementation of synchronous, user-centered alerts was associated with a system-level reduction in inappropriate DOAC prescribing. These findings support a complementary digital stewardship model in which high‑value, point‑of‑order alerts prevent routine prescribing errors, while clinical pharmacists focus on complex and longitudinal medication management. Trial Registration ClinicalTrials.gov NCT05351749; https://clinicaltrials.gov/study/NCT05351749

Authors

Publication Details

Journal
Journal of Medical Internet Research
Published
2026-11-19
DOI
https://doi.org/10.2196/101057
Primary Topic
Electronic Health Records Systems
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Use of Synchronous, Interruptive Electronic Health Record–Embedded Medication Alerts to Improve Evidence-Based Medication Prescribing: Randomized Comparative Effectiveness Trial of Two Prescriber Alerts

Shawna N. Smith, Geoffrey D. Barnes, Michael P. Dorsch, Michael S. M. Lanham et al.
Journal of Medical Internet Research
Electronic Health Records Systems
article

Use of Synchronous, Interruptive Electronic Health Record–Embedded Medication Alerts to Improve Evidence-Based Medication Prescribing: Randomized Comparative Effectiveness Trial of Two Prescriber Alerts

Shawna N. Smith, Geoffrey D. Barnes, Michael P. Dorsch, Michael S. M. Lanham, F. Jacob Seagull, Morris Fabbri, Josh Errickson, Seo Youn Choi, Anish Saraswat
article en

Abstract

Background Antithrombotic stewardship is critical for reducing preventable harm from inappropriate anticoagulant prescribing. Electronic health record (EHR)–embedded clinical decision support (CDS) alerts can prevent prescribing errors at the point of care, but their real-world effectiveness is variable and often limited by alert fatigue and poor workflow integration. Whether augmenting interruptive medication alerts with just‑in‑time access to clinical pharmacists improves prescriber response remains unclear. Objective This study aimed to (1) compare the effectiveness of synchronous, interruptive direct oral anticoagulant (DOAC) prescribing alerts with and without an embedded clinical pharmacist referral option for correcting inappropriate new prescriptions within 7 days, and (2) evaluate the system‑level impact of implementing synchronous DOAC alerts on inappropriate prescribing over time. Methods We conducted a prescriber‑level randomized comparative effectiveness trial within a large US academic health system. Prescribers who placed an inappropriate ambulatory apixaban or rivaroxaban order were randomized to receive an interruptive EHR alert either with or without an embedded clinical pharmacist referral link. The primary outcome was any change to the prescription within 7 days. In parallel, a system‑level interrupted time series analysis examined weekly proportions of inappropriate DOAC prescriptions (secondary outcomes) from 24 months before through 29 months after alert implementation. Exploratory outcomes included adverse events within 30 days and alert implementation metrics. Results Among 2082 prescribers writing DOAC prescriptions during the study period, 300 (14.4%) triggered at least one inappropriate prescription and were randomized; after prespecified exclusions, 758 alerts across 286 prescribers were analyzed. Overall, 28.9% (219/758) of alerts led to a prescription change within 7 days. The proportion of alerts leading to a prescription change did not differ between alerts with and without pharmacist referral (difference 1 percentage point [95% CI −7 to 9]). The system‑wide proportion of inappropriate DOAC prescriptions exhibited a significant downward preimplementation trend (−0.04 percentage points per week [95% CI −0.06 to −0.02]), followed by an immediate 3.5‑percentage‑point absolute reduction at alert launch (to 9.7%), with no subsequent slope change. Adverse events within 30 days were uncommon and similar across arms. Conclusions Adding an embedded pharmacist referral option to an interruptive DOAC prescribing alert did not increase short‑term prescription changes. However, the implementation of synchronous, user-centered alerts was associated with a system-level reduction in inappropriate DOAC prescribing. These findings support a complementary digital stewardship model in which high‑value, point‑of‑order alerts prevent routine prescribing errors, while clinical pharmacists focus on complex and longitudinal medication management. Trial Registration ClinicalTrials.gov NCT05351749; https://clinicaltrials.gov/study/NCT05351749

Journal of Medical Internet ResearchVol. 28
Electronic Health Records Systems
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon